Jean-Philippe Spano

4PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 16, 2025
Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.

Léonard Laurent, Baptiste Abbar, Kevin Bihan

|Feb 23, 2024
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in Cancer.

Arthur Géraud, David Combarel, Christian Funck-Brentano

|Nov 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.

Xiaofan Lu, Yann Vano, Alexandra Helleux

|Oct 27, 2022
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.

Omid Hamid, Alberto A Chiappori, John A Thompson

Pageof 1

Frequent Collaborators

2 joint publications

Paul Gougis

1 joint publications

Omid Hamid

1 joint publications

John A Thompson

1 joint publications

Adi Diab